Kamada Plasma

Kamada Plasma, established in 2021, specializes in the collection of human plasma. The collected plasma is being used as a source material for life-saving medicines, such as a treatment to prevent hemolytic disease in newborns. Kamada Plasma is a wholly owned subsidiary of Kamada currently operating a specialty plasma collection center in Beaumont Texas, U.S.A. This plasma collection facility was established by Blood and Plasma Research, Inc. in 1967 and was acquired by Kamada in 2021. Kamada Plasma is one out of only a few specialty plasma collection centers in the United States. It is licensed by the FDA and certified by the PPTA (Plasma Protein Therapeutics Association) and CLIA (Clinical Laboratory Improvement Act). Kamada Plasma intends to expand its plasma collection capabilities by investing in the current center and leveraging its FDA license to open additional centers in the U.S.